X4 Pharmaceuticals Inc share price logo

X4 Pharmaceuticals Inc Share Price

NASDAQ: XFOR

Small Cap

$4.18

+0.19

(+4.76%)

Live

as on

X4 Pharmaceuticals Inc Stock Performance

as on April 1, 2026 at 3:08 am IST

  • Day's Low

    Day's High

    $3.97
    $4.23
    downward going graph

    5.02%

    Downside

    1.20%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.35
    $7.50
    downward going graph

    67.70%

    Downside

    79.43%

    Upside

    downward going graph

X4 Pharmaceuticals Inc share price movements today

Previous Close
$3.99
Open
$3.97
Volume
183.1K
Day's Low - High
$3.97 - $4.23
52 Week Low - High
$1.35 - $7.50

X4 Pharmaceuticals Inc Historical Returns

1 Month Return
+ 19.82 %
3 Month Return
-0.25 %
1 Year Return
-43.74 %
3 Year Return
-84.71 %
5 Year Return
-98.46 %

X4 Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check X4 Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$367.3M

EPS (TTM)

-0.8733

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-78.6M

Revenue (TTM)

35.1M

Profit Margin

-225.56%

Return On Equity TTM

-75.99%

X4 Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of X4 Pharmaceuticals Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
X4 Pharmaceuticals Inc image
X4 Pharmaceuticals Inc
BUY$367.3M-98.46%NA-225.56%
Insmed Incorporated image
Insmed Incorporated
BUY$33.0B350.15%-16.34-210.54%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$42.1B123.88%136.798.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$110.0B106.23%28.2532.94%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$78.0B58.37%17.7931.41%

Stock Returns calculator for X4 Pharmaceuticals Inc Stock including INR - Dollar returns

The X4 Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

X4 Pharmaceuticals Inc investment value today

Current value as on today

₹64,826

Returns

-₹35,174

(-35.17%)

Returns from X4 Pharmaceuticals Inc Stock

-₹41,044 (-41.04%)

Dollar Impact

₹5,870 (+5.87%)

Analyst Recommendation on X4 Pharmaceuticals Inc Stock

Based on 12 analysts

BUY

83.33%

Buy

16.67%

Hold

0.00%

Sell

Based on 12 analysts, 83.33% of analysts recommend a 'BUY' rating for X4 Pharmaceuticals Inc. Average target price of $11.67

X4 Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on X4 Pharmaceuticals Inc.

What analysts predicted

64.18%UPSIDE

Target Price

$11.67

Current Price

$4.18

Analyzed by

12 Analysts

Target

$11.67

X4 Pharmaceuticals Inc target price $11.67, a slight upside of 64.18% compared to current price of $4.18. According to 12 analysts rating.

X4 Pharmaceuticals Inc Stock’s Investor Sentiment and Interest

Search interest for X4 Pharmaceuticals Inc Stock has increased by 298% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:298% versus previous 30 day period

X4 Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
3
-
0
0
1
28
1
1
2
Gross Profit
0
0
0
0
0
1
24
1
1
1
Operating Income
-27
-25
-37
-33
-34
-35
-9
-26
-27
-23
EBITDA
-26
-25
-37
-33
-34
-36
2
-23
-27
-38
Interest Expense
1
1
1
2
2
2
2
2
2
2
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-2
-19
-51
90
-36
-39
0
-25
-29
-23
Income Tax Expense
0
0
0
0
0
0
0
0
0
-
Net Income
-2
-19
-51
90
-36
-39
0
-25
-29
-23
Net Profit Margin
0.00%
-625.16%
0.00%
16133.75%
-6552.86%
-2776.92%
0.98%
-1304.66%
-1689.24%
-931.66%

X4 Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
3
3
3
-
-
-
2
35
Gross Profit
0
0
0
0
3
-1
-1
-1
1
28
Operating Income
-24
-36
-29
-46
-59
-75
-87
-107
-36
-86
EBITDA
-24
-35
-28
-46
-59
-73
-89
-94
-27
-85
Interest Expense
2
2
0
2
2
3
3
5
8
8
Depreciation
-
0
0
0
0
0
0
0
0
1
Income Before Tax
-22
-33
-33
-52
-61
-88
-93
-101
-37
-79
Income Tax Expense
2
1
3
3
0
0
0
0
0
0
Net Income
-22
-33
-33
-52
-62
-88
-93
-101
-37
-79
Net Profit Margin
0.00%
0.00%
-951.00%
-1760.23%
-2071.03%
0.00%
0.00%
0.00%
-1464.61%
-225.55%

X4 Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-19
-51
90
-36
-39
0
-25
-29
-23
Operating Cash Flow
-27
-33
-30
-34
-32
-12
-29
-27
-15
Investing Cash Flow
-4
-5
96
-15
-8
-3
23
-28
16
Financing Cash Flow
0
-
20
-
0
-
5
86
146
Change in Cash
-32
-38
86
-49
-41
-15
-1
30
147

X4 Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-33
-33
-52
-62
-88
-93
-101
-37
-79
Operating Cash Flow
-27
-25
-48
-58
-70
-77
-96
-130
-85
Investing Cash Flow
0
0
27
-1
0
0
-14
66
8
Financing Cash Flow
101
6
140
12
74
117
88
20
238
Change in Cash
73
-68
119
-47
2
39
-22
-43
161

Global Institutional Holdings in X4 Pharmaceuticals Inc

Funds
Holdings
Nantahala Capital Management, LLC
2.69%
Squarepoint Ops LLC
0.17%
AQR Capital Management LLC
0.12%
Samsara BioCapital, LLC
2.16%
StemPoint Capital LP
0.99%
See all

Insights on X4 Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, XFOR stock has moved up by 4.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Insmed Incorporated has given 101.0% return, outperforming this stock by 144.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Insmed Incorporated has given 799.2% return, outperforming this stock by 883.9%

About X4 Pharmaceuticals Inc

x4 pharmaceuticals is developing novel therapeutics designed to improve immune cell trafficking and reverse immune suppression, which is fundamental to treating cancer and certain rare, genetic primary immunodeficiency diseases. our oral, small molecule drug candidates inhibit the binding of chemokine cxcl12 to c-x-c receptor type 4 (cxcr4), a receptor-ligand pair that plays an essential role in normal immune surveillance. we are committed to advancing the fields of cancer immunotherapy and genetic immune disorders through innovation and investment in our proprietary clinical and preclinical pipeline. x4’s most advanced product candidate, x4p-001-rd, is in a phase 2/3 study in patients with whim syndrome, a rare genetic, primary immunodeficiency disease. x4p-001-io is currently under investigation in multiple phase 1/2 studies in refractory clear cell renal cell carcinoma (ccrcc) and melanoma. our third program, x4p-002, is in preclinical development and designed specifically for the t
OrganisationX4 Pharmaceuticals Inc
Headquarters61 North Beacon Street, Boston, MA, United States, 02134
IndustryBiotechnology
CEODr. Adam R. Craig M.B.A., M.D., Ph.D.
E-voting on sharesClick here to vote

Key Management of X4 Pharmaceuticals Inc

Name

Title

Dr. Adam R. Craig M.B.A., M.D., Ph.D.

Executive Chair

Mr. John P. Volpone M.B.A.

President & COO

Mr. David H. Kirske

CFO, Treasurer & Corporate Secretary

Dr. Richard Peters M.D., Ph.D.

Founder

Dr. Renato T. Skerlj Ph.D.

Founder

Dr. Keith T. Flaherty M.D.

Founder & Member of Corporate Advisory Board

FAQs

What is X4 Pharmaceuticals Inc share price today?

X4 Pharmaceuticals Inc share price today is $4.18 as on . X4 Pharmaceuticals Inc share today touched a day high of $4.23 and a low of $3.97.

What is the 52 week high and 52 week low for X4 Pharmaceuticals Inc share?

X4 Pharmaceuticals Inc share touched a 52 week high of $7.5 on and a 52 week low of $1.35 on . X4 Pharmaceuticals Inc stock price today i.e. is trending at $4.18,which is 44.27% down from its 52 week high and 209.63% up from its 52 week low.

What is X4 Pharmaceuticals Inc's market capitalisation today?

X4 Pharmaceuticals Inc market capitalisation is $0.00T as on .

How to invest in X4 Pharmaceuticals Inc Stock (XFOR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for X4 Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in X4 Pharmaceuticals Inc Shares that will get you 0.3589 shares as per X4 Pharmaceuticals Inc share price of $4.18 per share as on March 31, 2026 at 9:38 pm IST.

What is the minimum amount required to buy X4 Pharmaceuticals Inc Stock (XFOR) from India?

Indian investors can start investing in X4 Pharmaceuticals Inc (XFOR) shares with as little as ₹93.969 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹939.69 in X4 Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on X4 Pharmaceuticals Inc share’s latest price of $4.18 as on March 31, 2026 at 9:38 pm IST, you will get 2.3923 shares of X4 Pharmaceuticals Inc. Learn more about fractional shares .

What are the returns that X4 Pharmaceuticals Inc has given to Indian investors in the last 5 years?

X4 Pharmaceuticals Inc stock has given -98.46% share price returns and 29.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?